Dr. Tadashi Honda






Presentation List







 1. Saponins from Terminalia arjuna.
     T. Honda, T. Murae, T. Tsuyuki, and T. Takahashi;      Thirty-second Annual Meeting of the Chemical Society of Japan, 
     (April, 1975),Tokyo, Japan.


 2. Forced Wolff-Kishner Reduction of Olean-12-en-19-one Derivatives.
     T. Honda, T. Murae, T. Tsuyuki, and T. Takahashi;
     Thirty-sixth Annual Meeting of the Chemical Society of Japan,      (April, 1977), Osaka, Japan.


 3. Synthetic Studies of Quassinoids I.
     T. Honda, T. Murae, and T. Takahashi;
     Twenty-second Meeting on the Chemistry of Perfumes, Terpenoids, and Essential Oils,
     (October, 1978), Yokohama, Japan.


 4. Synthetic Studies of Quassinoids II.
     T. Honda, T. Murae, H. Kawai, and T. Takahashi;
     Twenty-second Meeting on the Chemistry of Perfumes, Terpenoids, and Essential Oils,
     (October, 1978), Yokohama, Japan.


5. Synthesis of 14aH-Picrasane Derivatives.
     T. Honda, T. Murae, Y. Kurata, S. Ohta, H. Hirota, Y. Iitaka, A. Itai, and T. Takahashi;
     Forty-third Annual Meeting of the Chemical Society of Japan,
     (April, 1981), Tokyo, Japan.


 6. Synthetic Studies of Quassinoids.
     T. Murae, T. Honda, S. Ohta, Y. Kurata, H. Matsuo, and T. Takahashi;
     Twenty-fourth Meeting on the Chemistry of Natural Products, 
     (October, 1981), Osaka, Japan.


 7. Studies on Antitumor Activity of Quassinoids I -Synthesis of Dehydroailanthinone and
     Novel Ailanthone Derivatives.
     T. Honda, K. Imao, M. Inoue, N. Nakatsuka, T. Tatsuoka, and T. Nakanishi;
     Hundred Third Annual Meeting of the Pharmaceutical Society of Japan,
     (April, 1983), Tokyo, Japan.


 8. Studies on Antitumor Activity of Quassinoids II -Synthesis of Bruceantine, Bruceantinol, and Novel Bruceolide derivatives.
     T. Honda, K. Imao, M. Inoue, N. Nakatsuka, T. Tatsuoka, and T. Nakanishi;
     Hundred Third Annual Meeting of the Pharmaceutical Society of Japan,
     (April, 1983), Tokyo, Japan.


 9. Studies on Antitumor Activity of Novel Ailanthone Derivatives.
     T. Honda, N. Nakatsuka, T. Tatsuoka, M. Matsui, T. Miura, Y. Fukuda, and T. Nakanishi;
     Forty-second Annual Meeting of the Japanese Cancer Association,
     (October, 1983), Nagoya, Japan.


10. Studies on Antitumor Activity of Quassinoids IV -Synthesis and Antitumor Activity of
     SUN2071 and Its Analogs.
     T. Honda, M. Inoue, K. Imao, N. Nakatsuka, T. Tatsuoka, T. Nakanishi, and 
     T. Noguchi;
     Hundred Fourth Annual Meeting of the Pharmaceutical Society of Japan,
     (March, 1984), Sendai, Japan.


11. Studies on Antitumor Activity of Quassinoids V -Structure-Activity Relationships of
     Antitumor Quassinoids.     T. Honda, M. Inoue, K. Imao, N. Nakatsuka, T. Tatsuoka, T. Nakanishi, and
     T. Noguchi;
     Hundred Fourth Annual Meeting of the Pharmaceutical Society of Japan,
     (March, 1984), Sendai, Japan.


12. Constituents of Seeds of Brucea javanica  (Yadanzi) I -Structure of Yadanziolide A, B, and C.
     S. Yoshimura, T. Sakaki, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, and T. Nakanishi;
     Twenty-eighth Meeting on the Chemistry of Perfumes, Terpenoids, and Essential Oils,
     (October, 1984), Kanazawa, Japan.


13. Constituents of Seeds of Brucea javanica  (Yadanzi) II-Structure of Yadanzioside A-H. 
     T. Sakaki, S. Yoshimura, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, and T. Nakanishi;
     Twenty-eighth Meeting on the Chemistry of Perfumes, Terpenoids, and Essential Oils,
     (October, 1984), Kanazawa, Japan.


14. Constituents of Seeds of Brucea javanica  (Yadanzi) III -Structure of Yadanziolide D.
     S. Yoshimura, T. Sakaki, M. Ishibashi, T. Tsuyuki, T. Takahashi, K. Matsushita, and T. Honda;
     Fiftieth Annual Meeting of the Chemical Society of Japan, (April, 1985), Tokyo, Japan.


15. Constituents of Seeds of Brucea javanica  (Yadanzi) IV -Structure of Yadanzioside K and M.
     T. Sakaki, S. Yoshimura, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, and 
     T. Nakanishi;
     Fiftieth Annual Meeting of the Chemical Society of Japan, (April, 1985), Tokyo, Japan.


16. Constituents of Seeds of Brucea javanica  (Yadanzi) V -Structure of Yadanzioside I, J, and L.
     S. Yoshimura, T. Sakaki, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, and
     T. Nakanishi;
     Fiftieth Annual Meeting of the Chemical Society of Japan, (April, 1985), Tokyo, Japan.


17. Isolation and Structure of Antileukemic Bitter Principles from Ya-dan-zi (Brucea javanica (L.) Merr).
     S. Yoshimura, T. Sakaki, M. Ishibashi, T. Tsuyuki, T. Takahashi, T. Honda, 
     T. Nakanishi, and K. Matsushita;
     Twenty-seventh Meeting on the Chemistry of Natural Products, 
     (October, 1985), Hiroshima, Japan.


18. Studies on Antitumor Activity of Quassinoids - Synthesis and Antitumor Activity of Novel Ailanthone Analogs.
     T. Honda, K. Imao, M. Inoue-Shiraishi, N. Nakatsuka, T. Tatsuoka, T. Nakanishi, and T. Noguchi;
     Sixth Symposium on the Development and Application of Naturally Occurring Drug Materials, (July, 1986), Nagoya, Japan.


19. Synthesis and Antitumor Activity of Ellipticine Nucleoside Derivatives.
     T. Honda, M. Inoue, M. Kato, T. Nakanishi, and T. Noguchi;
     Forty-fifth Annual Meeting of the Japanese Cancer Association,
     (October, 1986), Sapporo, Japan.


20. Synthesis of Antitumor Ellipticine Glycosides II -Drug Design and Synthetic Studies.     T. Honda, M. Inoue, M. Kato, and K. Shima;
     Hundred Seventh Annual Meeting of the Pharmaceutical Society of Japan,
     (April, 1987), Kyoto, Japan.


21. Synthesis of Antitumor Ellipticine Glycosides III -Synthesis and Antitumor Activity of Ellipticine Glycosides.
     T. Honda, M. Inoue, M. Kato, K. Shima, T. Nakanishi, and T. Noguchi;
     Hundred Seventh Annual Meeting of the Pharmaceutical Society of Japan,
     (April, 1987), Kyoto, Japan.


22. Synthesis of Antitumor Ellipticine Glycosides IV -Synthesis of SUN4599 (Elliprabin).
     T. Honda, M. Kato, T. Shimamoto, K. Shima, M. Inoue, T. Yoshida, T. Nakanishi, and T. Noguchi;
     Hundred Seventh Annual Meeting of the Pharmaceutical Society of Japan,
     (April, 1987), Kyoto, Japan.


23. Antitumor Effects of Ellipticine Glycosides, SUN4599 against Human Tumor Cells (CAM Method).
     J. Hashino, Y. Fukuda, T. Nakanishi, T. Honda, T. Sasaki, and T. Noguchi,
     Forty-sixth Annual Meeting of the Japanese Cancer Association, 
     (September, 1987), Tokyo, Japan.


24. Antitumor Effects of Ellipticine Glycosides, SUN4599 against Human Tumor Cells (SRC Method).
     T. Yoshida, Y. Fukuda, K. Sugiyama, T. Nakanishi, T. Honda, M. Kato, and 
     T. Noguchi;
     Forty-sixth Annual Meeting of the Japanese Cancer Association, 
     (September, 1987), Tokyo, Japan.


25. Molecular Mechanics Aided Structure Determination, Yadanziolide D.
     S. Yoshimura, K. Ogawa, T. Tsuyuki, T. Takahashi, and T. Honda;
     Sixteenth International Symposium on the Chemistry of Natural Products (IUPAC),
     (May 29 - June 3, 1988), Kyoto, Japan.


26. Studies on Mechanism of Action of SUN4599.
     Y. Yoshimura, M. Matsui, T. Honda, T. Nakanishi, and T. Noguchi;     Forty-seventh Annual Meeting of the Japanese Cancer Association, 
     (September, 1988), Tokyo, Japan.


27. Inhibitory Effect of SUN4599 on Metastasis of Murine Tumor.
     Y. Fukuda, J. Hashino, T. Yoshida, T. Nakanishi, T. Honda, T. Tsuruo, and
     T. Noguchi;
     Forty-seventh Annual Meeting of the Japanese Cancer Association, 
     (September, 1988), Tokyo, Japan.


28. Studies on SUN4599 (2-a-L-Arabinopyranosyl-9-hydroxyellipticinium Bromide), 
     A Novel and Highly Active Antitumor Agent.
     T. Honda, M. Kato, T. Shimamoto, M. Inoue, K. Shima, T. Nakanishi, and 
     T. Noguchi;
     Ninth Symposium on Medicinal Chemistry, (November, 1988), Tokyo, Japan.


29. Evaluation of Quassinoids for Amoebacidal Activity in Vitro and in Vivo.
     S. Kobayashi, T. Takeuchi, and T. Honda;
     Eighth International Congress of Protozoology, (1989), Japan.


30. Preparation and Properties of Monoclonal Antibody of SUN4599-resistant Tumor Cell.
     S. Yoshimura, M. Matsui, T. Nakanishi, T. Honda, and T. Noguchi;
     Forty-eighth Annual Meeting of the Japanese Cancer Association, 
     (October, 1989), Nagoya, Japan.


31. Studies on Mechanism of Action of SUN4599.     M. Matsui, S. Yoshimura, T. Nakanishi, T. Honda, T. Tsuruo, and T. Noguchi;
     Forty-eighth Annual Meeting of the Japanese Cancer Association, 
     (October, 1989), Nagoya, Japan.


32. Antitumor Spectra of SUN4599 against Human Tumor Cells.
     J. Hashino, Y. Fukuda, T. Yoshida, T. Nakanishi, T. Honda, and T. Noguchi
     Forty-eighth Annual Meeting of the Japanese Cancer Association, 
     (October, 1989), Nagoya, Japan.


33. A Novel Antitumor Agent. SUN4599, an Ellipticine Glycoside (1)
     -Antitumor Activity against Murine Tumors.
     S. Tsukagoshi, T. Tsuruo, T. Nakanishi, T. Honda, T. Noguchi, and K. Nitta
     Fifteenth International Cancer Congress,
     (August 16-22, 1990), Hamburg, Federal Republic of Germany.


34. A Novel Antitumor Agent. SUN4599, an Ellipticine Glycoside (2)
     -Effect against Human Tumor Cells.
     K. Nitta, S. Fujimoto, H. Tokita, T. Kunimoto, H. Baba, T. Nakanishi, T. Honda,
     T. Noguchi, and S. Tsukagoshi
     Fifteenth International Cancer Congress, 
     (August 16-22, 1990), Hamburg, Federal Republic of Germany.


35. A Novel Antitumor Agent. SUN4599, an Ellipticine Glycoside (3)
     -Mechanism of Action.
     T. Tsuruo, K. Kunimoto, H. Baba, T. Nakanishi, T. Honda, T. Noguchi,
     S. Tsukagoshi, and K. Nitta
     Fifteenth International Cancer Congress,
     (August 16-22, 1990), Hamburg, Federal Republic of Germany.


36. Antitumor Effect of SUN4599 against Human Tumor Cells.
     J. Hashino, Y. Fukuda, T. Yoshida, T. Nakanishi, T. Honda, and T. Noguchi
     Forty-ninth Annual Meeting of the Japanese Cancer Association,
     (July, 1990), Sapporo, Japan.


37. Studies on Mechanism of Action of SUN4599.
     S. Yoshimura, M. Matsui, T. Nakanishi, T. Honda, T. Tsuruo, and T. Noguchi
     Forty-ninth Annual Meeting of the Japanese Cancer Association,
     (July, 1990), Sapporo, Japan.


38. Antitumor Activity of SUN4599 on Various Drug-resistant Tumor Cells.
     M. Matsui, S. Yoshimura, T. Nakanishi, T. Honda, and T. Noguchi
     Forty-ninth Annual Meeting of the Japanese Cancer Association,
     (July, 1990), Sapporo, Japan.


39. Direct Observation of Anticarcinoma Synergism Involving Fluorescent Cytotoxin
     Formation inside Tumor Cells.
     T. Honda, D. Rideout, T. McCracken, and J. Jaworski
     American Chemical Society Meeting, (April, 1991), Atlanta, USA
.

40. Drug Delivery through Condensation of Two Prodrugs inside Tumor Cells: Direct
     Observation Using Fluorescence Microscopy.
     T. Honda, D. Rideout, M. McCarthy, T. McCracken, and J. Jaworski.
     Eighty-second Annual Meeting of the American Association for Cancer Research,
     (May 15-18, 1991), Houston, USA


41. Studies on Mechanism of Action of SUN4599.
     M. Matsui, S. Yoshimura, T. Nakanishi, T. Honda, T. Tsuruo, and T. Noguchi.
     Fiftieth Annual Meeting of the Japanese Cancer Association, 
     (September, 1991), Tokyo, Japan.


42. Antineoplastic Drug Assembly from Two Prodrugs inside Carcinoma Cells: a New Approach to Experimental Combination Chemotherapy.
     J. Patel, D. Rideout, T. Honda, M. McCarthy, T. McCracken, 
     T. Calogeropoulou, and J. Jaworski.
     American Chemical Society Meeting, (1991), USA.


43. Study of Triterpenoids as Cellular Differentiation Agents.
     Y. Wang, N. Suh, C. P. Williams, T. Honda, H. J. Finlay, G. W. Gribble, and 
     M. B. Sporn.
     New England Pharmacologists 25th Annual Meeting, (1996), USA.







Take me back to the GWG Research Group
.